Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

Share Price is delayed by 15 minutes
Get Live Data
3.25    0.00 (0.00%)
Bid:
3.00
Ask:
3.50
Spread: 0.50 (16.667%)
Market Cap: £1.03m
SNT Live PriceLast checked at - London Stock Exchange

Intraday Sabien Tech. Share Chart

New Factoring Facility

10 Nov 2025 07:00

RNS Number : 7693G
Sabien Technology Group PLC
10 November 2025
 

10 November 2025

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310.

Sabien Technology Group plc

("Sabien" or the "Company" or the "Group")

New Factoring Facility

 

Sabien Technology Group plc (AIM: SNT), a leader in Green Aggregation Strategy, will be entering into an invoice factoring facility with Parris Group Limited ("PGL"), the family office of Richard Parris, the Company's Executive Chairman (the "Facility"). The Facility will provide working capital for the Company as it expands sales of its M2G Cloud Connect service. The Facility is in addition to the funding already provided by PGL, as announced on 20 August 2024.

The Facility, which is subject to final contract, will have the following key terms:

· provide a non-recourse advance of 80% against any invoices assigned by Sabien Technology Limited, the Group's wholly owned UK trading subsidiary, responsible for the M2G Cloud Connect business;

· a finance charge of 2.5% per month on any advances, deducted from the proceeds of the assigned invoices;

· will be secured by way of a debenture.

Related party transactions

PGL is a company controlled by Richard Parris, a director of the Company, so the Facility constitutes a related party transaction pursuant to Rule 13 of the AIM Rules for Companies. Accordingly, the Independent Directors being Ed Sutcliffe, Charles Goodfellow and Ranald McGregor-Smith consider, having consulted with the Company's nominated adviser, Allenby Capital Limited, that the terms of the Facility are fair and reasonable insofar as Sabien's shareholders are concerned.

CFO's Comments

Ed Sutcliffe, CFO, commented:

"Sabien thanks Parris Group Limited for its continuing support. This facility will enable Sabien to deliver on its existing sales order pipeline, ensuring timely execution and fulfilment of customer commitments. It marks a significant step forward in scaling operations to meet growing demand."

 

For Further Information:

Sabien Technology Group plc

Richard Parris, Executive Chairman

 

 

 

+44 20 7993 3700

investors@sabien.com 

Allenby Capital Limited (Nominated Adviser)

John Depasquale / Nick Harriss / Vivek Bhardwaj 

 

 

+44 203 328 5656

 

AlbR Capital Limited (Broker)

Duncan Vasey / Lucy Williams 

 

 

+44 207 469 0930

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGREAAFNELNSFFA
Date   Source Headline
16th Dec 201912:30 pmRNSIssue of Equity
5th Dec 20194:30 pmRNSResult of AGM
13th Nov 20195:15 pmRNSNotice of AGM
6th Nov 20197:00 amRNSHolding(s) in Company
5th Nov 20197:00 amRNSDirectorate Change
4th Nov 201911:30 amRNSHolding(s) in Company
1st Nov 20191:00 pmRNSHolding(s) in Company
31st Oct 20195:00 pmRNSHolding(s) in Company
29th Oct 201911:05 amRNSSecond Price Monitoring Extn
29th Oct 201911:00 amRNSPrice Monitoring Extension
29th Oct 20199:05 amRNSSecond Price Monitoring Extn
29th Oct 20199:00 amRNSPrice Monitoring Extension
18th Oct 20192:47 pmRNSCorporate Update
30th Sep 20192:37 pmRNSTotal Voting Rights
27th Sep 20197:00 amRNSFinal Results
24th Sep 20197:00 amRNSBoard Changes
20th Sep 201910:51 amRNSHolding(s) in Company
10th Sep 201910:59 amRNSHolding(s) in Company
10th Sep 201910:56 amRNSHolding(s) in Company
3rd Sep 20197:00 amRNSBoard changes, subscription and trading update
28th Jun 20193:38 pmRNSHolding(s) in Company
11th Jun 20191:46 pmRNSNew contract award and trading update
30th May 20197:00 amRNSHolding(s) in Company
13th May 20197:00 amRNSPlacing
2nd Apr 20197:00 amRNSCorporate Update - Contract Win
14th Feb 20197:00 amRNSHalf-year Report
12th Feb 201910:29 amRNSHolding(s) in Company
12th Feb 201910:24 amRNSHolding(s) in Company
12th Feb 201910:24 amRNSHolding(s) in Company
4th Feb 20193:20 pmRNSCorporate Update - Orders Received
17th Jan 20197:00 amRNSDirectorate Change
21st Dec 20182:54 pmRNSResult of AGM and Board change
20th Dec 201810:29 amRNSDirector/PDMR Shareholding
20th Dec 201810:27 amRNSHolding(s) in Company
17th Dec 20183:47 pmRNSHolding(s) in Company
17th Dec 20182:54 pmRNSHolding(s) in Company
17th Dec 20182:50 pmRNSHolding(s) in Company
17th Dec 20182:49 pmRNSHolding(s) in Company
17th Dec 20187:00 amRNSHolding(s) in Company
13th Dec 20182:09 pmRNSResult of General Meeting and Board changes
28th Nov 20185:49 pmRNSNotice of AGM
28th Nov 20185:29 pmRNSAnnual Financial Report
27th Nov 20183:21 pmRNSNotice of GM
23rd Nov 201812:07 pmRNSConditional placing and proposed board changes
19th Nov 20185:47 pmRNSHolding(s) in Company
30th Aug 20184:36 pmRNSResult of Meeting, Change of Registered Office
7th Jun 20187:00 amRNSCorporate Update New Order Received
2nd May 201810:51 amRNSTotal Voting Rights
27th Mar 20184:33 pmRNSPDMR Shareholding
26th Mar 20187:00 amRNSFundraise and appointment of sole broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.